| pubmed-article:16370155 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16370155 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:16370155 | lifeskim:mentions | umls-concept:C0000768 | lld:lifeskim |
| pubmed-article:16370155 | lifeskim:mentions | umls-concept:C0262950 | lld:lifeskim |
| pubmed-article:16370155 | lifeskim:mentions | umls-concept:C0022661 | lld:lifeskim |
| pubmed-article:16370155 | lifeskim:mentions | umls-concept:C0006681 | lld:lifeskim |
| pubmed-article:16370155 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:16370155 | lifeskim:mentions | umls-concept:C0768119 | lld:lifeskim |
| pubmed-article:16370155 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:16370155 | pubmed:dateCreated | 2005-12-22 | lld:pubmed |
| pubmed-article:16370155 | pubmed:abstractText | Renal osteodystrophy is a common complication of end-stage renal disease (ESRD) and is a major cause of morbidity in patients with ESRD. High serum levels of phosphorus, calcium and parathyroid hormone are associated with the development of this disease. The effects on bone of treatment with lanthanum carbonate, a new phosphate binder, and calcium carbonate were assessed in patients with ESRD. | lld:pubmed |
| pubmed-article:16370155 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16370155 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16370155 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16370155 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16370155 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16370155 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16370155 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16370155 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16370155 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16370155 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16370155 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:16370155 | pubmed:issn | 0301-0430 | lld:pubmed |
| pubmed-article:16370155 | pubmed:author | pubmed-author:DentonJJ | lld:pubmed |
| pubmed-article:16370155 | pubmed:author | pubmed-author:FreemontA JAJ | lld:pubmed |
| pubmed-article:16370155 | pubmed:author | pubmed-author:HoylandJ AJA | lld:pubmed |
| pubmed-article:16370155 | pubmed:author | pubmed-author:Lanthanum... | lld:pubmed |
| pubmed-article:16370155 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16370155 | pubmed:volume | 64 | lld:pubmed |
| pubmed-article:16370155 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16370155 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16370155 | pubmed:pagination | 428-37 | lld:pubmed |
| pubmed-article:16370155 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:16370155 | pubmed:meshHeading | pubmed-meshheading:16370155... | lld:pubmed |
| pubmed-article:16370155 | pubmed:meshHeading | pubmed-meshheading:16370155... | lld:pubmed |
| pubmed-article:16370155 | pubmed:meshHeading | pubmed-meshheading:16370155... | lld:pubmed |
| pubmed-article:16370155 | pubmed:meshHeading | pubmed-meshheading:16370155... | lld:pubmed |
| pubmed-article:16370155 | pubmed:meshHeading | pubmed-meshheading:16370155... | lld:pubmed |
| pubmed-article:16370155 | pubmed:meshHeading | pubmed-meshheading:16370155... | lld:pubmed |
| pubmed-article:16370155 | pubmed:meshHeading | pubmed-meshheading:16370155... | lld:pubmed |
| pubmed-article:16370155 | pubmed:meshHeading | pubmed-meshheading:16370155... | lld:pubmed |
| pubmed-article:16370155 | pubmed:meshHeading | pubmed-meshheading:16370155... | lld:pubmed |
| pubmed-article:16370155 | pubmed:meshHeading | pubmed-meshheading:16370155... | lld:pubmed |
| pubmed-article:16370155 | pubmed:meshHeading | pubmed-meshheading:16370155... | lld:pubmed |
| pubmed-article:16370155 | pubmed:meshHeading | pubmed-meshheading:16370155... | lld:pubmed |
| pubmed-article:16370155 | pubmed:meshHeading | pubmed-meshheading:16370155... | lld:pubmed |
| pubmed-article:16370155 | pubmed:meshHeading | pubmed-meshheading:16370155... | lld:pubmed |
| pubmed-article:16370155 | pubmed:meshHeading | pubmed-meshheading:16370155... | lld:pubmed |
| pubmed-article:16370155 | pubmed:meshHeading | pubmed-meshheading:16370155... | lld:pubmed |
| pubmed-article:16370155 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:16370155 | pubmed:articleTitle | The effects of lanthanum carbonate and calcium carbonate on bone abnormalities in patients with end-stage renal disease. | lld:pubmed |
| pubmed-article:16370155 | pubmed:affiliation | Osteoarticular Pathology, The Medical School, University of Manchester, UK. tony.freemont@man.ac.uk | lld:pubmed |
| pubmed-article:16370155 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16370155 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:16370155 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:16370155 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16370155 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16370155 | lld:pubmed |
